Harbor Investment Advisory’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117K Buy
+1,494
New +$102K 0.01% 515
2024
Q3
Sell
-4
Closed -$209 1217
2024
Q2
$209 Buy
+4
New +$175 ﹤0.01% 1179
2023
Q3
Sell
-1,869
Closed -$67.4K 1248
2023
Q2
$67.4K Hold
1,869
0.01% 616
2023
Q1
$71.4K Buy
1,869
+167
+10% +$7.83K 0.01% 596
2022
Q4
$96.8K Hold
1,702
0.02% 501
2022
Q3
$67K Hold
1,702
0.01% 580
2022
Q2
$75K Hold
1,702
0.01% 574
2022
Q1
$68K Sell
1,702
-252
-13% -$8.98K 0.01% 653
2021
Q4
$79K Hold
1,954
0.01% 607
2021
Q3
$79K Hold
1,954
0.01% 592
2021
Q2
$89K Buy
1,954
+198
+11% +$8.76K 0.01% 539
2021
Q1
$73K Hold
1,756
0.01% 573
2020
Q4
$75K Buy
1,756
+650
+59% +$23.4K 0.01% 516
2020
Q3
$29K Buy
+1,106
New +$30.8K 0.01% 645

Other funds holding HALO

Harbor Investment Advisory's HALO Position: Q2 2026 in Review

Harbor Investment Advisory opened a new position in Halozyme (HALO) in Q2 2026: 1,494 shares worth $117K. The stake represents 0.01% of the portfolio and ranks #515 among its holdings. This is a return to the name: Harbor Investment Advisory previously reported a position in HALO as recently as Q2 2024.

Harbor Investment Advisory first reported a position in HALO in Q3 2020 and has held it in 14 quarters since. 82 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Harbor Investment Advisory held 1,494 shares of Halozyme worth $117K as of Q2 2026.
  • Halozyme was a new Harbor Investment Advisory position in Q2 2026.
  • Halozyme made up 0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #515 holding.
  • Harbor Investment Advisory first reported a position in Halozyme in Q3 2020 and has held it in 14 quarters since.
  • 82 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.